Apolipoprotein E Receptor 2 Interactions with the N-Methyl-D-aspartate Receptor
Lists
Only you see this
Abstract
In our previous studies we showed that apoE treatment of neurons activated ERK 1/2 signaling, and activation was blocked by treatment with inhibitors of the low density lipoprotein receptor family, the N-methyl-d-aspartate (NMDA) receptor antagonist MK 801, and calcium channel blockers. We hypothesized an interaction between the low density lipoprotein receptor family members and the NMDA receptor. In the present study, we confirmed through co-immunoprecipitation experiments an interaction between the apoE receptor, ApoEr2, and NMDAR1 through their extracellular domains. We also found that the PDZ1 domain of PSD95, a postsynaptic scaffolding protein, interacted with the C terminus of ApoEr2 via an alternatively spliced, intracellular exon. This interaction between ApoEr2 and PSD95 in neurons was modulated by NMDA receptor activation and an ApoEr2 ligand. We also found that the PDZ2 domain of PSD95 interacted with the NR2A and NR2B subunits of NMDA receptors. Full-length PSD95 increased cell surface levels of ApoEr2 and its cleavage, resulting in increases in secreted ApoEr2 and C-terminal fragments of ApoEr2. These studies suggest that ApoEr2 can form a multiprotein complex with NMDA receptor subunits and PSD95. In our previous studies we showed that apoE treatment of neurons activated ERK 1/2 signaling, and activation was blocked by treatment with inhibitors of the low density lipoprotein receptor family, the N-methyl-d-aspartate (NMDA) receptor antagonist MK 801, and calcium channel blockers. We hypothesized an interaction between the low density lipoprotein receptor family members and the NMDA receptor. In the present study, we confirmed through co-immunoprecipitation experiments an interaction between the apoE receptor, ApoEr2, and NMDAR1 through their extracellular domains. We also found that the PDZ1 domain of PSD95, a postsynaptic scaffolding protein, interacted with the C terminus of ApoEr2 via an alternatively spliced, intracellular exon. This interaction between ApoEr2 and PSD95 in neurons was modulated by NMDA receptor activation and an ApoEr2 ligand. We also found that the PDZ2 domain of PSD95 interacted with the NR2A and NR2B subunits of NMDA receptors. Full-length PSD95 increased cell surface levels of ApoEr2 and its cleavage, resulting in increases in secreted ApoEr2 and C-terminal fragments of ApoEr2. These studies suggest that ApoEr2 can form a multiprotein complex with NMDA receptor subunits and PSD95. Apolipoprotein E (apoE) 2The abbreviations used are: apoE, apolipoprotein E; ApoEr2, apoE receptor 2; NMDA, N-methyl-d-aspartate; NR, N-methyl-d-aspartate receptor; ERK, extracellular signal-regulated kinase; LTP, long term potentiation; LRP, low density lipoprotein receptor-related protein; PSD, postsynaptic density; GFP, green fluorescent protein; HA, hemagglutinin; FBS, fetal bovine serum; NMDAR, N-methyl-d-aspartate receptor; CTF, C-terminal fragments. allows lipoproteins to introduce a variety of lipophilic molecules to cells (1Li Y. Cam J. Bu G. Mol. Neurobiol. 2001; 23: 53-67Crossref PubMed Scopus (118) Google Scholar). Cholesterol and lipids are essential in remodeling neuronal membranes and developing new growth terminals. These processes mediate synaptic plasticity and responses to neurodegeneration. ApoE-containing lipoproteins are endocytosed into cells via apoE receptors, including the low density lipoprotein receptor, low density lipoprotein receptor-related protein (LRP1), very low density lipoprotein receptor, apoE receptor type 2 (ApoEr2), and the LR11 receptor (2Beffert U. Stolt P.C. Herz J. J. Lipid Res. 2004; 45: 403-409Abstract Full Text Full Text PDF PubMed Scopus (127) Google Scholar). Ligand activation of these receptors has also been implicated in a variety of neuronal signaling processes. These receptors play roles in neuronal migration during development (3Dulabon L. Olson E.C. Taglienti M.G. Eisenhuth S. McGrath B. Walsh C.A. Kreidberg J.A. Anton E.S. Neuron. 2000; 27: 33-44Abstract Full Text Full Text PDF PubMed Scopus (505) Google Scholar), calcium influx through the NMDA channel (4Bacskai B.J. Xia M.Q. Strickland D.K. Rebeck G.W. Hyman B.T. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 11551-11556Crossref PubMed Scopus (172) Google Scholar, 5Qui Z. Crutcher K.A. Hyman B.T. Rebeck G.W. Neuroscience. 2003; 122: 291-303Crossref PubMed Scopus (78) Google Scholar), and neurite outgrowth (6Qui Z. Hyman B.T. Rebeck G.W. J. Biol. Chem. 2004; 279: 34948-34956Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar). Our previous work showed that apoE and an apoE-derived peptide also activated the extracellular signal-regulated kinase 1/2 (ERK 1/2) (7Hoe H.S. Harris D.C. Rebeck G.W. J. Neurochem. 2005; 93: 145-155Crossref PubMed Scopus (97) Google Scholar). The activation of ERK 1/2 by apoE was blocked by an inhibitor to the low density lipoprotein receptor family, the NMDA receptor antagonist MK 801, and calcium channel blockers. We also found that apoE promoted extracellular and intramembranous cleavages of these receptors, affecting metabolism of their C-terminal fragments (8Hoe H.S. Rebeck G.W. Brain Res. Mol. Brain Res. 2005; 137: 31-39Crossref PubMed Scopus (81) Google Scholar). Several in vivo and in vitro studies have supported roles for apoE and apoE receptors in signaling processes involving NMDA channels. ApoE targeted replacement mice revealed that long term potentiation (LTP) was significantly greater in animals expressing mouse apoE or human apoE3 than in apoE knock-out (9Trommer B.L. Shah C. Yun S.H. Gamkrelidze G. Pasternak E.S. Ye G.L. Sotak M. Sullivan P.M. Pasternak J.F. Ladu M.J. Neuroreport. 2004; 15: 2655-2658Crossref PubMed Scopus (100) Google Scholar), apoE2, or apoE4 mice (10Grootendorst J. Bour A. Vogel E. Kelche C. Sullivan P.M. Dodart J.C. Bales K. Mathis C. Behav. Brain Res. 2005; 159: 1-14Crossref PubMed Scopus (116) Google Scholar). Mice deficient in the very low density lipoprotein receptor and ApoEr2 also have moderate defects in LTP (11Weeber E.J. Beffert U. Jones C. Christian J.M. Forster E. Sweatt J.D. Herz J. J. Biol. Chem. 2002; 277: 39944-39952Abstract Full Text Full Text PDF PubMed Scopus (513) Google Scholar). Biochemical and immunohistochemical studies showed that the LRP1 interacts with NMDA receptors and the postsynaptic density protein PSD95 (12May P. Rohlmann A. Bock H.H. Zurhove K. Marth J.D. Schomburg E.D. Noebels J.L. Beffert U. Sweatt J.D. Weeber E.J. Herz J. Mol. Cell Biol. 2004; 24: 8872-8883Crossref PubMed Scopus (171) Google Scholar). These data suggest that LRP1, and potentially other apoE receptors, can modulate LTP (12May P. Rohlmann A. Bock H.H. Zurhove K. Marth J.D. Schomburg E.D. Noebels J.L. Beffert U. Sweatt J.D. Weeber E.J. Herz J. Mol. Cell Biol. 2004; 24: 8872-8883Crossref PubMed Scopus (171) Google Scholar). The heteromeric NMDA receptors (NMDAR) are ligand-gated ion channels. The NR1 subunit is present in all NMDARs in combination with NR2 (NR2A-NR2D) or NR3 subunits (13Wenthold R.J. Prybylowski K. Standley S. Sans N. Petralia R.S. Annu. Rev. Pharmacol. Toxicol. 2003; 43: 335-358Crossref PubMed Scopus (293) Google Scholar). The trafficking of the NMDA receptor to the synapse and its location within the synapse are dependent on various extracellular and intracellular interactions. The NR2 subunits interact, through their C termini, with PSD95, a protein found abundantly in the postsynaptic density. PSD95 has three PDZ domains, one Src homology 3 domain, and one guanylate kinase domain (14McGee A. Dakoji S.R. Osen O. Bredt D.S. Lim W.A. Prehoda K.E. Mol. Cell. 2001; 8: 1291-1301Abstract Full Text Full Text PDF PubMed Scopus (200) Google Scholar, 15Tavares G.A. Panepucci E. Brunger A.T. Mol. Cell. 2001; 8: 1313-1325Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar). Proteins that belong to this family have been termed membrane-associated guanylate kinases. The large network of interactions between PSD95 and proteins of this family is critical for regulation of postsynaptic development (16El-Husseini A.E. Schnell E. Chetkovich D.M. Nicoll R.A. Bredt D.S. Science. 2000; 290: 1364-1368Crossref PubMed Google Scholar, 17Sala C. Peich V. Wilson N.R. Passafaro M. Liu G. Shend M. Neuron. 2001; 31: 115-130Abstract Full Text Full Text PDF PubMed Scopus (581) Google Scholar) and plasticity (18Migaud M. Charlesworth P. Dempster M. Webster L.C. Watabe A.M. Makhinson M. He Y. Ramsay M.F. Morris R.G. Morrison J.H. O'Dell T.H. Grant S.G. Nature. 1998; 396: 433-439Crossref PubMed Scopus (971) Google Scholar). These studies suggest that apoE receptors may interact with NMDA receptors, potentially affecting their activity. In this work, we investigated the mechanisms of ApoEr2 interactions with NMDA receptors. We demonstrate that NMDAR1 interacts with the extracellular portion of ApoEr2 and affects its processing. Furthermore, we found that PSD95, through its first PDZ domain, interacts with the intracellular domain of ApoEr2 and, through its second PDZ domain, interacts with NMDAR2 subunits. We suggest that PSD95 functions as a link between ApoEr2 and NMDAR2 subunits, thus potentially modulating calcium influx, cell signaling, and LTP. Vector Construction—We produced several deletion constructs of ApoEr2. Each construct of mouse ApoEr2 was generated with a C-terminal HA tag in the pcDNA flux3 expression vector: 1) residues 1-214; 2) residues 215-401; 3) residues 402-614; 4) residues 615-842; 5) residues 1-614; 6) residues 1-826; and 7) residues 1-842. The ApoEr2 constructs lacked ligand binding repeats 4-6 and included the alternately spliced cytoplasmic insert (19Brandes C. Kahr L. Stockinger W. Hiesberger T. Schneider W.J. Nimpf J. J. Biol. Chem. 2001; 276: 22160-22169Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar). We also generated several constructs of C-terminal ApoEr2 containing only exon 18, only exon 19, or exons 18 and 19. Full-length PSD95 with a C-terminal GFP tag was the kind gift of Dr. David Bredt (University of California, San Francisco). We generated five deletion constructs, also with C-terminal GFP tags: 1) residues 337-2175; 2) residues 735-2175; 3) residues 1047-2175; 4) residues 1-336; and 5) 1-2175 residues. Recombinant DNA was confirmed by sequencing and expression of correctly sized proteins was confirmed by Western blot using an anti-GFP antibody. Cell Lines and Culture Conditions—COS7 and human embryonic kidney cells were maintained in Opti-MEM (Invitrogen) with 10% fetal bovine serum (FBS, Invitrogen) in a 10% CO2 incubator. Cells were transiently transfected with 0.5-1 μg of plasmid in FuGENE 6 (Roche Diagnostics) according to the manufacturer's protocol and cultured 24 h in Dulbecco's modified Eagle's medium containing 10% FBS. For co-transfections, cells were similarly transfected with 0.5-1 μg of each plasmid in FuGENE 6 (Roche) and cultured 24 h in Dulbecco's modified Eagle's medium with 10% FBS. After 24 h the cells were transferred to Opti-MEM serum-free media (Invitrogen) and then receptor ligands were added, including an apoE-derived peptide. The apoE tandem repeat peptide (LRKLRKRLLLRKLRKRLL) was synthesized by Johns Hopkins University of Medicine (Biosynthesis and Sequencing Facility, Baltimore, MD). Antibodies—We used antibodies anti-HA (Abcam), anti-c-myc (Abcam), anti-GFP (Roche), anti-FLAG (Sigma), and anti-PSD95 (Abcam). Antibody 5810 was raised in a rabbit against a recombinant protein of the first three ligand binding repeats of mouse ApoEr2 (20Hoe H.S. Wessner D. Beffert U. Becker A.G. Matsuoka Y. Rebeck G.W. Mol. Cell Biol. 2005; 25: 9259-9268Crossref PubMed Scopus (101) Google Scholar), and was the kind gift of Dr. Uwe Beffert. Antibodies against NR1 (monoclonal, recognizing NR2A against and NR2B (monoclonal, recognizing were of Dr. of ApoEr2 cells were transiently transfected with constructs for ApoEr2, or PSD95, and then cultured in Dulbecco's modified Eagle's medium containing 10% for 24 Cells were maintained for 24 h in serum-free ApoEr2 was by Western blot the Proteins in media were by transferred to and with the 5810 antibody. ApoEr2 C-terminal fragments were in cell with inhibitors (Roche) and inhibitors Proteins were and using the HA by Western Cell mouse embryonic were embryonic mice as Z. Strickland D.K. Hyman B.T. Rebeck G.W. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar). Brain were and for After and were and was Cells were then transferred to medium containing serum and were on a density of 2 For of the cells in vitro were with MK for or NMDA for Cells were in cell was to of NMDA receptors in the cell cells were with and in containing and and For levels of cell proteins were for 2 h with the antibodies in the of protein The were then three with and in The were on transferred to and blocked with The were with antibodies for antibodies were by and to Cell cells were transiently transfected with ApoEr2 and cultured 24 h in Dulbecco's modified Eagle's medium containing 10% FBS. After 24 medium was to serum After 24 cells were with and surface proteins were with with for was to were with Cells were in by on for on and by 2 was to and h were with and h with including levels of proteins were then by and surface proteins were by Cell embryonic kidney cells were with in and to with for Cells were three in and then with for in and with for were with Cells were with and in cells were with and on an with a or with a with a were were in and to of proteins that with cell were through in the to the P. The Brain in San Scholar). to the were to the of were in the between the to the that was by The a was to the and to the were in the the as the of the were with and the other 2 apoE peptide a of for This of co-immunoprecipitation and experiments were a of were using of with using for with as ApoEr2 with our previous studies we showed that ligand binding to apoE receptors in neurons intracellular kinase including extracellular signal-regulated kinase 1/2 (ERK 1/2) (7Hoe H.S. Harris D.C. Rebeck G.W. J. Neurochem. 2005; 93: 145-155Crossref PubMed Scopus (97) Google Scholar). ERK 1/2 activation NMDA receptors and calcium influx, that apoE receptors interact with NMDA receptors (7Hoe H.S. Harris D.C. Rebeck G.W. J. Neurochem. 2005; 93: 145-155Crossref PubMed Scopus (97) Google Scholar). ApoEr2 interacted with the NMDA receptor, we transfected cells with ApoEr2 and and the with Full-length ApoEr2 with NR1 In the of was Western blot of cell confirmed that levels of NR1 were was in the of and NR1 in transfected cells this interaction was the of proteins in a we ApoEr2 and NR1 in and neuronal We mouse with 5810 and the with NR1 antibody. in transfected ApoEr2 and NR1 NR1 was in experiments with serum of ApoEr2 neuronal in of NR1 ApoEr2 was in experiments with serum a we NR1 and with a of NR1 in neuronal of ApoEr2 with domain of ApoEr2 interacted with we transfected cells with ApoEr2 deletion constructs with constructs and 5) and C-terminal constructs and Proteins of were each construct to as by Western with anti-HA We cell with and the with the extracellular domain of ApoEr2 and 7) with NR1 containing all or of the intracellular domain to a greater than the construct containing only the extracellular domain construct for a protein with only the extracellular domain and the its with NR1 is an interaction between of extracellular ligand growth and with also that ApoEr2 with proteins proteins NR1 protein was similarly in all NR1 and NR2 ApoEr2 (8Hoe H.S. Rebeck G.W. Brain Res. Mol. Brain Res. 2005; 137: 31-39Crossref PubMed Scopus (81) Google an interaction between NR1 and ApoEr2 raised the that this by we cells with NR1 and ApoEr2 and in the levels of secreted ApoEr2 and ApoEr2 of the ApoEr2 of NR1 increased secreted ApoEr2 and ApoEr2 with cells with the were in ApoEr2 These data suggest that the interaction between NR1 affects the of ApoEr2. We then NR2 subunits also ApoEr2 processing. cells were with NR2 subunits and ApoEr2. We found that the NR2B and subunits increased levels of secreted ApoEr2 and ApoEr2 affecting ApoEr2 levels NR2A and on ApoEr2 was an in the secreted of ApoEr2 These data suggest that various NR2 subunits can ApoEr2 processing. PSD95 with the of showed that PSD95, a postsynaptic scaffolding protein, interacted with ApoEr2 in a and M. M. M.F. J. J.A. Stockinger W. Nimpf J. Herz J. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, U. Weeber E.J. A. S. Sweatt J.D. G. M. Herz J. Neuron. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). this we transfected cells with constructs of ApoEr2 and PSD95, cell with and the with anti-GFP PSD95 with the intracellular domain of ApoEr2 4) and with with the extracellular of ApoEr2 and The expression of the PSD95 constructs levels of ApoEr2 The of PSD95 with ApoEr2 extracellular the levels of expression of the domains, as by Western blot with the HA as PSD95 interacted with the cytoplasmic portion of ApoEr2. of the cytoplasmic domain of ApoEr2 interacted with PSD95, we generated several constructs of ApoEr2 containing only exon 18 construct only exon construct or exons 18 and construct We found that PSD95 with exon exon 18 of ApoEr2 The PDZ1 of PSD95 with domain of PSD95 interacted with ApoEr2. We generated deletion constructs of PSD95 and cells with deletion constructs or ApoEr2. we found that PSD95 with ApoEr2 each PSD95 construct the PDZ1 domain with ApoEr2 and data we confirmed that levels of ApoEr2 were in all and PSD95 constructs and were present in transfected cells The of the of ApoEr2 for only PSD95 that the interaction is of of proteins in the We then generated a PSD95 deletion construct containing only the PDZ1 domain construct We cells with and ApoEr2, with and with ApoEr2 with PSD95 PDZ1 the PDZ1 domain of PSD95 interacts with ApoEr2, the PDZ2 or domains. PSD95 and of Cell the interaction of PSD95 with ApoEr2 of ApoEr2. For these experiments we cells with ApoEr2 and various PSD95 deletion constructs, and the of secreted ApoEr2 and ApoEr2 In we found that PSD95 increased secreted ApoEr2 and ApoEr2 We then the PSD95 PDZ1 domain ApoEr2 processing. For these experiments we cells with ApoEr2 and PSD95 PDZ1 and the of secreted ApoEr2 and ApoEr2 In we found that the PDZ1 domain of PSD95 also increased secreted ApoEr2 and ApoEr2 PSD95 interactions with ApoEr2 promoted the of ApoEr2. The of PSD95 on ApoEr2 by increased of ApoEr2 to the cell cell surface levels of ApoEr2, we cells with ApoEr2 and PSD95 constructs, cell surface proteins cell with and ApoEr2. of cell surface ApoEr2 were increased by PSD95, were by PSD95 constructs that interact with ApoEr2 of ApoEr2 were the transfected cells ApoEr2 was in the of in experiments of experiments that levels of cell surface ApoEr2 were significantly increased by by the of PSD95 We a second to surface levels of ApoEr2. embryonic kidney cells were transfected with ApoEr2 and one of several PSD95 ApoEr2 was in cells using the 5810 The only the and ApoEr2 in the or greater levels of surface ApoEr2 were ApoEr2 was in the of the PSD95 PDZ1 domain or PSD95 with the PSD95 construct PDZ1 the PDZ1 domain of PSD95 and PSD95 promoted surface levels of ApoEr2. The PDZ2 of PSD95 with NR2A and NR2B showed that subunits NR2A and NR2B interact with the PDZ2 domain of PSD95 M. E. M. J. PubMed Google Scholar). these in our we transfected cells with PSD95 constructs and NR2 constructs, cell with and with Full-length PSD95 and the deletion construct containing PDZ2 1) showed interactions with the NR2A subunit We confirmed that expression levels of NR2A were PSD95 and the deletion construct containing PDZ2 showed interactions with the NR2B subunit NR2B was levels in all These data suggest that PSD95 a link between the ApoEr2 and NMDA receptor by binding ApoEr2 via PDZ1 and NR2 subunits via of PSD95 and ApoEr2 by of NMDA or ApoE complex of ApoEr2, PSD95, and NMDARs by binding of and to extracellular of these receptors. We the interaction between ApoEr2 and PSD95 is dependent on the by neurons with NMDA or antagonist MK Cell were with ApoEr2 and were with in transfected ApoEr2 and PSD95 neuronal we found that MK and NMDA of PSD95 with ApoEr2 These data suggest that the interaction on the of the NMDA receptor. We found that ApoEr2 interacted with NMDA in mouse We we also an interaction between ApoEr2 and PSD95 in with our in vitro PSD95 with ApoEr2 We then the interaction between ApoEr2 and PSD95 was by ligands that ApoEr2. We the apoE-derived peptide into the and of the into the for each was the of ApoE peptide treatment increased of PSD95 with ApoEr2 of Western apoE that was significantly increased by apoE peptide treatment These suggest that apoE also modulate the interaction between ApoEr2 and PSD95, the of this have to in In this work, we found that the apoE receptor ApoEr2 interacted with NMDA receptors in ApoEr2 interacted with NR1 subunits through an extracellular interaction and ApoEr2 interacted with PSD95, potentially a link with NR2 subunits The cytoplasmic domain of ApoEr2 interacted with the first PDZ domain of PSD95 NR2 subunits interacted with the second PDZ domain The interactions with NR2 subunits and PSD95 also the and trafficking of ApoEr2 3 and the surface levels and of ApoEr2. binding of ligands to ApoEr2 or NMDA receptors the of PSD95 with ApoEr2 These data suggest that the of NMDA receptors and ApoEr2 may for or the interaction of ApoEr2 with PSD95. These are with studies that that apoE receptors neuronal calcium influx via NMDA receptors. several have that apoE receptors kinase signaling by affecting calcium influx Z. Crutcher K.A. Hyman B.T. Rebeck G.W. Neuroscience. 2003; 122: 291-303Crossref PubMed Scopus (78) Google Scholar, H.S. Harris D.C. Rebeck G.W. J. Neurochem. 2005; 93: 145-155Crossref PubMed Scopus (97) Google Scholar, U. Weeber E.J. A. S. Sweatt J.D. G. M. Herz J. Neuron. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar, N. N. M. A. T. M. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar). showed a of apoE receptors on calcium influx via NMDA receptors (4Bacskai B.J. Xia M.Q. Strickland D.K. Rebeck G.W. Hyman B.T. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 11551-11556Crossref PubMed Scopus (172) Google Scholar). studies found that ApoEr2 LTP (11Weeber E.J. Beffert U. Jones C. Christian J.M. Forster E. Sweatt J.D. Herz J. J. Biol. Chem. 2002; 277: 39944-39952Abstract Full Text Full Text PDF PubMed Scopus (513) Google Scholar). ApoEr2 was found in the and to form with NR2A and these on the alternatively spliced cytoplasmic exon that we also in this work U. Weeber E.J. A. S. Sweatt J.D. G. M. Herz J. Neuron. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). this exon also was for LTP and functions in mice U. Weeber E.J. A. S. Sweatt J.D. G. M. Herz J. Neuron. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). The interactions between ApoEr2 and NMDA receptor subunits to by other in vitro and in vivo to are in protein trafficking or receptor in We that apoE receptor promoted by the of extracellular ligands (8Hoe H.S. Rebeck G.W. Brain Res. Mol. Brain Res. 2005; 137: 31-39Crossref PubMed Scopus (81) Google Scholar). we have found that the of NMDA receptor subunits also the of ApoEr2 3 and The of apoE receptors for the of the intracellular domain of the receptor, proteins to the to the (20Hoe H.S. Wessner D. Beffert U. Becker A.G. Matsuoka Y. Rebeck G.W. Mol. Cell Biol. 2005; 25: 9259-9268Crossref PubMed Scopus (101) Google Scholar). The also for the of signaling via apoE receptors, and thus by the of NMDA receptors. these data we have generated a of ApoEr2 affecting NMDA receptor through intracellular and extracellular interactions ApoEr2 to NR1 through its extracellular domain, we a of ApoEr2 that this is that ApoEr2 constructs NMDAR1 trafficking and thus its interaction with work the extracellular interactions. ApoEr2 PSD95 via its PDZ1 domain, a link to NR2 subunits, to the PSD95 PDZ2 studies have that NR2 proteins PSD95 through their C-terminal M. E. M. J. PubMed Google Scholar). ApoEr2 interacts with PSD95 through a cytoplasmic domain that is the C terminus and U. Weeber E.J. A. S. Sweatt J.D. G. M. Herz J. Neuron. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). this domain of ApoEr2 is alternatively spliced, of ApoEr2 PSD95 and PSD95 binding to ApoEr2 also increases the of ApoEr2 on the cell of its extracellular binding of PSD95 to ApoEr2 affects the interaction of ApoEr2 with NMDA receptors and its ApoE receptors interact with various as and PSD95, their trafficking and processing. These the metabolism of the functions of these receptors and the molecules with interact in our of the functions of apoE, and may the of We have a between ApoEr2 and NMDA receptors in the that apoE NMDA receptor and mechanisms of We Dr. for NMDA receptor antibodies and We Dr. for and We Dr. David Bredt for the PSD95 construct and Dr. Uwe Beffert for the antibody.
BibTeX
@article{hoe2005apolipoprotein,
author = {Hyang‐Sook Hoe and Ana Pocivavsek and Geetanjali Chakraborty and Zhanyan Fu and Stefano Vicini and Michael Ehlers and G. William Rebeck},
title = {{Apolipoprotein E Receptor 2 Interactions with the N-Methyl-D-aspartate Receptor}},
journal = {Journal of Biological Chemistry},
year = {2005},
doi = {10.1074/jbc.m509380200},
}Loading related content...